Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Verreck

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Journal of Immunology|June 1, 1993
HLA-DR beta chain residue 86 controls DR alpha beta dimer stabilityF A Verreck, A Termijtelen, F Koning
European Journal of Immunology|April 12, 2001
Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DMF A Verreck, C A Fargeas, G J Hämmerling
Trends in Immunology|November 8, 2001
Setting a course for intervening in host-pathogen interactionsF A Verreck, R R de Vries, T H Ottenhoff
Microbes and Infection|December 13, 2000
Human deficiencies in type 1 cytokine receptors reveal the essential role of type 1 cytokines in immunity to intracellular bacteriaT H Ottenhoff, T de Boer, C E Verhagen, et al.
European Journal of Immunology|February 1, 1994
Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencingF A Verreck, A van de Poel, A Termijtelen, et al.
Immunogenetics|January 1, 1996
Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52F A Verreck, A van de Poel, J W Drijfhout, et al.
Tissue Antigens|April 1, 1995
DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulinF A Verreck, D Elferink, C J Vermeulen, et al.
International Immunology|March 1, 1996
The generation of SDS-stable HLA DR dimers is independent of efficient peptide bindingF A Verreck, C Vermeulen, A V Poel, et al.
Cancer Research|July 29, 1998
Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopesT van Hall, N E van de Rhee, S P Schoenberger, et al.
The Journal of Experimental Medicine|August 22, 2000
Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cellsC E Verhagen, de Boer T, H H Smits, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|June 1, 1993
HLA-DR beta chain residue 86 controls DR alpha beta dimer stabilityF A Verreck, A Termijtelen, F Koning
European Journal of Immunology|April 12, 2001
Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DMF A Verreck, C A Fargeas, G J Hämmerling
Trends in Immunology|November 8, 2001
Setting a course for intervening in host-pathogen interactionsF A Verreck, R R de Vries, T H Ottenhoff
Microbes and Infection|December 13, 2000
Human deficiencies in type 1 cytokine receptors reveal the essential role of type 1 cytokines in immunity to intracellular bacteriaT H Ottenhoff, T de Boer, C E Verhagen, et al.
European Journal of Immunology|February 1, 1994
Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencingF A Verreck, A van de Poel, A Termijtelen, et al.
Immunogenetics|January 1, 1996
Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52F A Verreck, A van de Poel, J W Drijfhout, et al.
Tissue Antigens|April 1, 1995
DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulinF A Verreck, D Elferink, C J Vermeulen, et al.
International Immunology|March 1, 1996
The generation of SDS-stable HLA DR dimers is independent of efficient peptide bindingF A Verreck, C Vermeulen, A V Poel, et al.
Cancer Research|July 29, 1998
Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopesT van Hall, N E van de Rhee, S P Schoenberger, et al.
The Journal of Experimental Medicine|August 22, 2000
Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cellsC E Verhagen, de Boer T, H H Smits, et al.
Pageof 1